Ficiently disseminate to mucosal tissues (39, 54). Moreover, the recent demonstration of therapeutic efficacy of a human papilloma virus vaccine delivered by DNA or electroporation in a Phase IIB randomized study in humans (557) demonstrates the efficacy of a pDNA platform in inducing mucosal T cell responses in humans. This delivers the possibility of working with a pDNA vaccination targeting the